Long-term indenolol (Securpres* * Indenolol - Securpres: Poli, Milan, Italy.) in hypertension

A. S. Montenero, M. Mazzari, G. Schiavoni, E. Coppola, U. Manzoli

Research output: Contribution to journalArticlepeer-review


Eleven of 20 hypertensives admitted to a four-week trial with indenolol (Securpres) given as monotherapy or in combination with diuretics carried on treatment for an overall period of 12 months. In all these patients, the satisfactory arterial pressure levels attained during the first few weeks of the trial remained unchanged throughout the study. Myocardial oxygen consumption was reduced both at rest and following cyclo-ergometer exericse. No orthostatic hypotension or bradycardia phenomena occurred. Tolerance was excellent; no side-effects were observed.

Original languageEnglish
Pages (from-to)423-431
Number of pages9
JournalClinical Trials Journal
Issue number5
Publication statusPublished - 1985


  • diuretics
  • Hypertension
  • indenolol
  • monotherapy

ASJC Scopus subject areas

  • Pharmacology (medical)


Dive into the research topics of 'Long-term indenolol (Securpres* * Indenolol - Securpres: Poli, Milan, Italy.) in hypertension'. Together they form a unique fingerprint.

Cite this